These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 7564349

  • 1. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension.
    French JF, Anderson BA, Downs TR, Dage RC.
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):107-13. PubMed ID: 7564349
    [Abstract] [Full Text] [Related]

  • 2. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T, Tikkanen I, Rockell MD, Allen TJ, Johnston CI, Cooper ME, Burrell LM.
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [Abstract] [Full Text] [Related]

  • 3. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
    Farina NK, Johnston CI, Burrell LM.
    J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of omapatrilat in low, normal, and high renin experimental hypertension.
    Trippodo NC, Robl JA, Asaad MM, Fox M, Panchal BC, Schaeffer TR.
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):363-72. PubMed ID: 9544878
    [Abstract] [Full Text] [Related]

  • 8. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P, Benrezzak O, Arsenault D, Pheng LH, Blouin A, Cayer J, Beaudoin M, Belleville K, Sirois P, Nantel F, Jeng AY, Battistini B.
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I, Tikkanen T, Cao Z, Allen TJ, Davis BJ, Lassila M, Casley D, Johnston CI, Burrell LM, Cooper ME.
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [Abstract] [Full Text] [Related]

  • 11. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P, Buclin T, Nussberger J, Décosterd LA, La Roche SD, Brunner-Ferber F, Brunner HR, Biollaz J.
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [Abstract] [Full Text] [Related]

  • 12. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q, Touyz RM, Schiffrin EL.
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [Abstract] [Full Text] [Related]

  • 13. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
    Rossi GP, Cavallin M, Rizzoni D, Bova S, Mazzocchi G, Agabiti-Rosei E, Nussdorfer GG, Pessina AC.
    J Hypertens; 2002 Jul; 20(7):1451-9. PubMed ID: 12131544
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
    French JF, Flynn GA, Giroux EL, Mehdi S, Anderson B, Beach DC, Koehl JR, Dage RC.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):180-6. PubMed ID: 8301555
    [Abstract] [Full Text] [Related]

  • 15. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
    Fournié-Zaluski MC, Gonzalez W, Turcaud S, Pham I, Roques BP, Michel JB.
    Proc Natl Acad Sci U S A; 1994 Apr 26; 91(9):4072-6. PubMed ID: 8171037
    [Abstract] [Full Text] [Related]

  • 16. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T, Okahara A, Nose M, Ikuse T, Matsumura Y.
    Biol Pharm Bull; 2000 Jul 26; 23(7):820-5. PubMed ID: 10919359
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin and angiotensin-converting enzyme, in rats and humans.
    Laurent S, Boutouyrie P, Azizi M, Marie C, Gros C, Schwartz JC, Lecomte JM, Bralet J.
    Hypertension; 2000 May 26; 35(5):1148-53. PubMed ID: 10818079
    [Abstract] [Full Text] [Related]

  • 18. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
    Daull P, Blouin A, Sirois P, Nantel F, Jeng AY, Battistini B.
    J Cardiovasc Pharmacol; 2004 Nov 26; 44 Suppl 1():S398-401. PubMed ID: 15838331
    [Abstract] [Full Text] [Related]

  • 19. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA, Carlson JE, McTaggart PA, Qiao Y, Webb R, Chatelain R, Jeng AY, Trapani AJ.
    J Med Chem; 1996 Aug 02; 39(16):3158-68. PubMed ID: 8759637
    [Abstract] [Full Text] [Related]

  • 20. Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.
    Burrell LM, Farina NK, Balding LC, Johnston CI.
    Hypertension; 2000 Dec 02; 36(6):1105-11. PubMed ID: 11116133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.